251 related articles for article (PubMed ID: 35187964)
21. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
[TBL] [Abstract][Full Text] [Related]
23. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
[TBL] [Abstract][Full Text] [Related]
24. Impact of anemia on in-stent restenosis after percutaneous coronary intervention.
Hu H; Wang S; Tang G; Zhai C; Shen L
BMC Cardiovasc Disord; 2021 Nov; 21(1):548. PubMed ID: 34798833
[TBL] [Abstract][Full Text] [Related]
25. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
26. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
[TBL] [Abstract][Full Text] [Related]
27. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
[TBL] [Abstract][Full Text] [Related]
29. Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study.
Chen J; Wu K; Cao W; Shao J; Huang M
Lipids Health Dis; 2023 Aug; 22(1):121. PubMed ID: 37553680
[TBL] [Abstract][Full Text] [Related]
30. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
[TBL] [Abstract][Full Text] [Related]
31. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
Gupta PK; Balachander J
Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
[TBL] [Abstract][Full Text] [Related]
32. Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.
Komura N; Tsujita K; Yamanaga K; Sakamoto K; Kaikita K; Hokimoto S; Iwashita S; Miyazaki T; Akasaka T; Arima Y; Yamamoto E; Izumiya Y; Yamamuro M; Kojima S; Tayama S; Sugiyama S; Matsui K; Nakamura S; Hibi K; Kimura K; Umemura S; Ogawa H
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317348
[TBL] [Abstract][Full Text] [Related]
33. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
34. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
35. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass.
Akboga MK; Yayla C; Balci KG; Ozeke O; Maden O; Kisacik H; Temizhan A; Aydogdu S
Thorac Cardiovasc Surg; 2017 Jun; 65(4):315-321. PubMed ID: 27111497
[No Abstract] [Full Text] [Related]
37. Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.
Zhou J; Chai D; Dai Y; Wang A; Yan T; Lu S
Clin Appl Thromb Hemost; 2022; 28():10760296221107888. PubMed ID: 35706375
[TBL] [Abstract][Full Text] [Related]
38. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
Tanındı A; Ekici B; Töre HF
Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
[TBL] [Abstract][Full Text] [Related]
39. The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis.
Wang L; Zhang Y; Yu B; Zhao J; Zhang W; Fan H; Ren Z; Liang B
Front Endocrinol (Lausanne); 2023; 14():1127425. PubMed ID: 37056665
[TBL] [Abstract][Full Text] [Related]
40. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
